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1. Introduction 
Catabolism of plasma triglyceride-rich lipoproteins 
is thought to be mediated by a specific triglyceride 
hydrolase, lipoprotein lipase in the capillary bed of 
extrahepatic tissues [ 11. Lipoprotein lipase is released 
into plasma after heparin administration [2], and it 
has been assumed that all triglyceride lipase activity 
in postheparin plasma is due to this enzyme. Recent 
studies have shown, however, that a second tri- 
glyceride lipase activity is present in postheparin 
plasma of man and experimental animals [ 3-61. This 
activity differs from lipoprotein lipase in its resistance 
to protamine and 1 M NaCl and in its lack of activa- 
tion by serum cofactors. The ‘salt-resistant’ or 
‘protamine-insensitive’ lipase is present in heparin 
perfusate of liver [7,8], but not in postheparin plasma 
of hepatectomized animals [ 5,9], and has been 
assumed to originate from liver. 
In the present study we describe a refined purifica- 
tion procedure for human postheparin triglyceride 
lipases. By this method the saltresistant riglyceride 
hydrolase is separated into three subfractions. Further 
purification of these fractions and of lipoprotein 
lipase is attained by calcium gel chromatography. 
After this treatment the enzyme activities are no 
more retained by heparin-Sepharose. 
2. Material and methods 
2.1. Enzyme assay 
Triglyceride hydrolase activity was assayed in 
duplicate with a synthetic [ l4 C] triolein substrate 
emulsified in the presence of 5% gum arabic [lo]. 
North-Holland Publishing Company - Amsterdam 
2.2. Sources of enzyme 
Postheparin plasma was obtained by plasma- 
pheresis from healthy young males after injection of 
heparin (100 III/kg body weight, Heparin, Medica, 
Finland). Plasma was stored frozen at -20°C until 
assayed. 
2.3. Enzyme purification 
In a typical experiment 400 ml of postheparin 
plasma from a single donor was mixed with 100 ml of 
20% triglyceride emulsion (Intralipid@, Vitrum, 
Stockholm, Sweden). The mixture was incubated at 
37°C for 15 min. After centrifugation at 76 000 g 
for 60 min, the fat layer at the top of the centrifuge 
tube was collected. The clear infranatant was again 
mixed with Intralipid@ and the incubation and cen- 
trifugation were repeated. The fat layers were com- 
bined and added to 250 ml centrifuge tubes contain- 
ing 150 ml of cold acetone. After stirring the tubes 
were centrifuged at 20 000 g for 10 min. The precipi- 
tate was then washed with 150 ml of acetone and 
twice with 70 ml of ether and finally dried under 
nitrogen. The dried powder was dissolved in 5 mM 
sodium barbital buffer, pH 7.4, containing 20% of 
glycerol. The solution was centrifuged at 27 000 g for 
15 min. The pellet contained no triglyceride lipase 
activity. 
The clear supernatant was applied on a Sepharose 
4B column (2.5 X 17.5 cm) containing covalently 
bound heparin [ 111. The column was equilibrated 
with 0.15 M NaCl in 5 mM sodium barbital buffer, 
pH 7.4, containing 20% glycerol. After washing with 
0.4 M NaCl the enzyme was eluted with a linear NaCl 
gradient (600 ml; 0.4 ml/min) from 0.4 to 1.5 M NaCl 
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in 5 mM sodium barbital buffer, pH 7.4, containing 
20% glycerol. 
2.4. Calcium phosphate gel adsorption 
Calcium phosphate gel adsorption was carried out 
as described by Fielding [ 121. Pooled fractions from 
the heparin-Sepharose chromatography were mixed 
with calcium phosphate gel (Sigma Chemical Co. 
7 mg of dry gel/ml of eluate) and the suspension was 
stirred at 4°C overnight. After centrifugation at 
9000 g for 10 min, the supernatant was removed and 
the gel was washed with 20 ml of 50 mM NH40H- 
NH4Cl buffer, pH 8.3, containing 0.5 mM potassium 
oleate, 10 mM desoxycholate and 0.1 M potassium 
oxalate and finally with 50 mM NHdOH-N&Cl 
buffer containing 0.1 M potassium oxalate. The 
enzymes were eluted twice with 4 ml of 50 mM 
sodium citrate-50 mM NHaOH-NH4Cl buffer, pH 
8.3, containing 0.5 mM potassium oleate. 
2.5. Antisera 
Antiserum against salt-resistant lipase has been 
described earlier [ 131. The antiserum against lipo- 
protein lipase from bovine milk [ 141 was a gift from 
Drs. Hemell, Egelrud and Olivecrona, Umea”, Sweden. 
3. Results 
Optimal results were obtained in the formation of 
the enzyme-substrate complex by adding 1 part of 
20% Intralipid@ to 4 parts of postheparin plasma. 
Under these conditions more than 30% of the total 
lipolytic activity in postheparin plasma was recovered 
after delipidation of the enzyme-substrate complex. 
Immunological studies indicated that 40-45% of the 
salt-resistant lipase and 5- 10% of the serum stimu- 
lated lipase activity remained in the infranatant after 
two treatments with Intralipid@. Thus, both lipases 
bind to Intralipid@ although the affinity of the salt- 
resistant lipase is distinctly lower. 
When the delipidated preparation was subjected to 
affinity chromatography on heparin-Sepharose, several 
peaks of triglyceride lipase activity were constantly 
seen (fig.1). Plasma obtained from two donors 
yielded three separate peaks (II, III and IV, fig.l), 
while an additional peak (I) eluting in front of the 
other fractions was discernible in the preparation 
from a third donor. The four peaks of activity were 
eluted at 0.5 (I), 0.7 (II), 0.85 (III) and at 1.05 M 
NaCl (IV), respectively. The effect of serum and NaCl 
on the activity of lipase in fractions II-IV is shown in 
fig.2. Peak I (not shown), II and III were not 
FRACTION NUMBER 
Fig. 1. Heparm-Sepharose chromatography of delipidated triglyceride lipase preparation obtained after the enzyme-substrate 
complex step (for details see Material and methods). Triglyceride lipase activity (o-o) and NaCl concentration (A-A) are as 
indicated. Peaks I, II, III and IV were pooled as shown by the black bars in the panel. 
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Fig. 2. Effect of NaCl and serum on the activity of triglyceride lipase in fractions II (a--o), III (o-o) and IV (m-m). The 
assays were performed under standard conditions varying the concentrations of serum and NaCl in the assay medium. 
inhibited by 1 M NaCl and did not require the 
presence of serum for full activity. In contrast to 
these fractions, triglyceride lipase in peak IV was 
activated &fold by serum and was strongly inhibited 
by high salt concentrations. 
The lipase fractions were further purified by 
adsorption on calcium phosphate gel. All four 
fractions were retained by the gel and could be 
eluted with a citrate-containing buffer. This step 
resulted in I.52.5fold additional purification of all 
four fractions with the recovery of lipase activity 
varying between 10 and 40%. The specific activities 
of the final preparations were 107,1103, 801 and 
1789 bmol FFA released/mg protein/hr for the 
fractions 1, II, III and IV, respectively. 
#en the enzyme preparations were subjected to 
chromatography on heparin-Sepharose after the 
calcium phosphate gel step, none of the activities were 
retained by the column. The recoveries of the enzyme 
activities in this step were constantly more than 
100% ranging from 140 to 290% in different batches 
of enzymes. The reason for this activation is not 
known. Antiserum prepared against the salt-resistant 
lipase abolished the activity in fractions I, II and III 
while the activity in fractions IV was not changed 
(fig.4). An antiserum against the lipoprotein lipase 
from bovine milk precipitated the activity in fraction 
IV but did not affect the enzymes in the three other 
preparations. 
PEAK I 
Fig. 3. Effect of antiserum against salt-resistant lipase from 
human postheparin plasma (----) and antiserum against 
lipoprotein lipase from bovine milk (----- ) on the activity 
of triglyceride lipase in fractions I, II, III and IV (see text). 
Lipase fractions were preincubated at 4°C for 2 hr with the 
indicated amounts of antisera (diluted to a constant volume 
with normal rabbit serum). Open symbols (0) indicate the 
assays performed at 0.1 M NaCl and solid symbols (0) those 
performed at 1.0 M NaCl concentration. 
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4. Discussion 
The purification procedure described in this paper 
involves two steps specific for triglyceride lipases. The 
use of enzyme-substrate complex formation gives 
excellent purification of triglyceride lipases and 
simultaneously circumvents the laborious acetone- 
ether treatment of plasma employed in earlier studies 
[5,6]. Both lipoprotein lipase and salt-resistant lipase 
were complexed to Intralipid@ although the affinity of 
the latter activity to triolein emulsion was distinctly 
lower. Chromatography of the delipidated preparation 
on heparin-Sepharose resulted in four separate frac- 
tions, three of which had the characteristics of salt- 
resistant lipase. The fourth fraction clearly differed 
from the others and was identical with lipoprotein 
lipase in its behaviour towards various activators and 
inhibitors. 
Further purification of the four lipase preparations 
by calcium phosphate gel chromatography yielded 
fractions which were no more retained by heparin- 
Sepharose. This observation is in agreement with the 
results of Fielding [ 121 who has shown that rat post- 
heparin plasma triglyceride lipase is not retained by 
heparin-Sepharose after calcium phosphate gel treat- 
ment. On the other hand, it is obvious from our 
results that complete separation of lipoprotein lipase 
and salt-resistant lipase can be achieved only by 
heparin-Sepharose chromatography performed before 
calcium phosphate gel treatment. 
The presence of two immunologically different 
triglyceride lipases in postheparin plasma has earlier 
been inferred from studies using antisera against salt- 
resistant lipase [ 131 and bovine milk lipoprotein 
lipase [ 141. The present study provides conclusive 
evidence for this suggestion by demonstrating that 
three of the fractions separated on heparin-Sepharose 
were precipitated by antiserum against salt-resistant 
lipase while the fourth was immunologically similar 
to bovine milk lipoprotein lipase. The molecular basis 
for the chromatographic heterogeneity of salt- 
resistant triglyceride lipase is currently not known. 
Further studies are needed to establish whether these 
fractions represent activities with different origins 
and/or physiological functions or whether they are 
formed from a single enzyme species during the 
purification. 
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